Meta-analysis addressing the impact of sodium-glucose Co-transporter-2 inhibitors on the risk for atrial fibrillation among individuals with heart failure with preserved ejection fraction
Dimitrios Patoulias,
Theodoros Michailidis,
Athina Dimosiari,
George Kassimis,
Nikolaos Fragakis
Affiliations
Dimitrios Patoulias
Second Department of Cardiology, Aristotle University of Thessaloniki, General Hospital “Hippokration”, Greece; Department of Internal Medicine, European Interbalkan Medical Center, Thessaloniki, Greece; Corresponding author. Second Department of Cardiology, General Hospital “Hippokration”, Konstantinoupoleos 49, 54642, Thessaloniki, Greece.
Theodoros Michailidis
Second Department of Internal Medicine, Aristotle University of Thessaloniki, General Hospital “Hippokration”, Greece
Athina Dimosiari
Department of Internal Medicine, European Interbalkan Medical Center, Thessaloniki, Greece
George Kassimis
Second Department of Cardiology, Aristotle University of Thessaloniki, General Hospital “Hippokration”, Greece
Nikolaos Fragakis
Second Department of Cardiology, Aristotle University of Thessaloniki, General Hospital “Hippokration”, Greece
